Patents by Inventor Kentaro NUMAJIRI

Kentaro NUMAJIRI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11154534
    Abstract: An object of the present invention is to provide a lipid particle composition containing panobinostat or a salt thereof and exhibiting a high bone marrow-targeting capability, and a pharmaceutical composition including the lipid particle composition. According to the present invention, provided is a lipid particle composition containing panobinostat or a salt thereof, in which a lipid particle contains a phospholipid and cholesterol.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: October 26, 2021
    Assignee: FUJIFILM Corporation
    Inventors: Yuta Yoshino, Hayato Ogura, Mikinaga Mori, Taisuke Endo, Kentaro Numajiri, Ritsuko Hori
  • Publication number: 20210128471
    Abstract: An object of the present invention is to provide a liposome composition containing a liposome having an excellent leakage rate of a nucleic acid analog anticancer agent, and a method for producing the same. According to the present invention, there are provided a liposome composition containing a liposome which (1) contains a nucleic acid analog anticancer agent and in which (2) a content ratio of a lysophospholipid contained in a lipid forming the liposome with respect to a total amount of phospholipids other than the lysophospholipid contained in the lipid forming the liposome is 0.01 mol % to 5 mol % and (3) a nucleic acid analog anticancer agent/lipid ratio is 2 mass % to 10 mass %, and a method for producing the same.
    Type: Application
    Filed: January 4, 2021
    Publication date: May 6, 2021
    Applicant: FUJIFILM Corporation
    Inventors: Takahiro SEKIGUCHI, Mikinaga MORI, Kentaro NUMAJIRI, Hiroyuki KITAOKA
  • Publication number: 20190314335
    Abstract: An object of the present invention is to provide a lipid particle composition containing panobinostat or a salt thereof and exhibiting a high bone marrow-targeting capability, and a pharmaceutical composition including the lipid particle composition. According to the present invention, provided is a lipid particle composition containing panobinostat or a salt thereof, in which a lipid particle contains a phospholipid and cholesterol.
    Type: Application
    Filed: June 21, 2019
    Publication date: October 17, 2019
    Applicant: FUJIFILM Corporation
    Inventors: Yuta YOSHINO, Hayato OGURA, Mikinaga MORI, Taisuke ENDO, Kentaro NUMAJIRI, Ritsuko HORI
  • Publication number: 20180243215
    Abstract: An object of the present invention is to provide a liposome composition containing a liposome having an excellent leakage rate of a nucleic acid analog anticancer agent, and a method for producing the same. According to the present invention, there are provided a liposome composition containing a liposome which (1) contains a nucleic acid analog anticancer agent and in which (2) a content ratio of a lysophospholipid contained in a lipid forming the liposome with respect to a total amount of phospholipids other than the lysophospholipid contained in the lipid forming the liposome is 0.01 mol % to 5 mol % and (3) a nucleic acid analog anticancer agent/lipid ratio is 2 mass % to 10 mass %, and a method for producing the same.
    Type: Application
    Filed: May 1, 2018
    Publication date: August 30, 2018
    Applicant: FUJIFILM Corporation
    Inventors: Takahiro SEKIGUCHI, Mikinaga MORI, Kentaro NUMAJIRI, Hiroyuki KITAOKA